Last reviewed · How we verify
DTaP-IPV combination vaccine
DTaP-IPV combination vaccine is a Combination vaccine Biologic drug developed by Boryung Biopharma Co., Ltd.. It is currently in Phase 3 development for Prevention of diphtheria, tetanus, pertussis, and poliomyelitis in infants and children.
This combination vaccine stimulates the immune system to produce antibodies and cellular immunity against diphtheria, tetanus, pertussis, and poliovirus by delivering inactivated toxins and viral antigens.
This combination vaccine stimulates the immune system to produce antibodies and cellular immunity against diphtheria, tetanus, pertussis, and poliovirus by delivering inactivated toxins and viral antigens. Used for Prevention of diphtheria, tetanus, pertussis, and poliomyelitis in infants and children.
At a glance
| Generic name | DTaP-IPV combination vaccine |
|---|---|
| Sponsor | Boryung Biopharma Co., Ltd. |
| Drug class | Combination vaccine |
| Modality | Biologic |
| Therapeutic area | Immunology |
| Phase | Phase 3 |
Mechanism of action
DTaP-IPV is a quadrivalent vaccine combining diphtheria and tetanus toxoids, acellular pertussis antigen, and inactivated poliovirus. It works by presenting these antigens to the immune system, triggering both humoral (antibody) and cell-mediated immune responses that provide protective immunity against these four infectious diseases. The vaccine prevents disease by enabling rapid immune recognition and neutralization of the pathogens upon natural exposure.
Approved indications
- Prevention of diphtheria, tetanus, pertussis, and poliomyelitis in infants and children
Common side effects
- Injection site pain, redness, or swelling
- Fever
- Irritability or fussiness
- Drowsiness
- Loss of appetite
Key clinical trials
- Post-marketing Surveillance Study for the Safety of a DTaP-IPV- HB-PRP~T Vaccine in Republic of Korea
- Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa (PHASE3)
- Immunogenicity of a Combined Diphtheria-Tetanus-recombinant Acellular Pertussis (DTaP) Vaccine in Healthy Toddlers (PHASE2, PHASE3)
- Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants (PHASE2)
- Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial (PHASE3)
- Study of Concomitant Administration of the sIPV and DTaP or MMR (PHASE4)
- A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP) (PHASE3)
- Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DTaP-IPV combination vaccine CI brief — competitive landscape report
- DTaP-IPV combination vaccine updates RSS · CI watch RSS
- Boryung Biopharma Co., Ltd. portfolio CI
Frequently asked questions about DTaP-IPV combination vaccine
What is DTaP-IPV combination vaccine?
How does DTaP-IPV combination vaccine work?
What is DTaP-IPV combination vaccine used for?
Who makes DTaP-IPV combination vaccine?
What drug class is DTaP-IPV combination vaccine in?
What development phase is DTaP-IPV combination vaccine in?
What are the side effects of DTaP-IPV combination vaccine?
Related
- Drug class: All Combination vaccine drugs
- Manufacturer: Boryung Biopharma Co., Ltd. — full pipeline
- Therapeutic area: All drugs in Immunology
- Indication: Drugs for Prevention of diphtheria, tetanus, pertussis, and poliomyelitis in infants and children
- Compare: DTaP-IPV combination vaccine vs similar drugs
- Pricing: DTaP-IPV combination vaccine cost, discount & access